Zomedica Corp. (ZOM)
NYSEAMERICAN: ZOM · Real-Time Price · USD
0.120
-0.001 (-0.66%)
Feb 21, 2025, 4:00 PM EST - Market closed
Zomedica Revenue
Zomedica had revenue of $7.00M in the quarter ending September 30, 2024, with 10.24% growth. This brings the company's revenue in the last twelve months to $26.73M, up 11.33% year-over-year. In the year 2023, Zomedica had annual revenue of $25.19M with 33.05% growth.
Revenue (ttm)
$26.73M
Revenue Growth
+11.33%
P/S Ratio
4.39
Revenue / Employee
$185,604
Employees
144
Market Cap
117.40M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ZOM News
- 10 days ago - Zomedica Improves Efficiency and Cuts Costs by Moving to New Headquarters - Accesswire
- 16 days ago - Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis - Accesswire
- 6 weeks ago - Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market - Accesswire
- 2 months ago - Zomedica Launches Two New Quantitative Assays on the TRUFORMA(R) Platform: Canine NT-proBNP and Progesterone - Accesswire
- 2 months ago - Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer - Accesswire
- 3 months ago - Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - Accesswire
- 3 months ago - Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - Accesswire
- 3 months ago - Noble Capital Markets Initiates Equity Research Coverage on Zomedica - Accesswire